BioClinica - Global Clinical Trial Solutions. Real-World Results News

Bio-Imaging Technologies, Inc. Shareholders Approve Company's Name Change to BioClinica, Inc. Bio-Imaging Technologies, Inc. (NASDAQ: BITI), a global provider of clinical trial services, has received shareholder approval to change its name to BioClinica, Inc., effective immediately.
View press release
Bioclinica's Jonathan Andrus Named Chair of DIA's eClinicall SIAC Bio-Imaging Technologies, Inc., (NASDAQ: BITI) d/b/a BioClinica a leading global provider of clinical trial services, announced today that Jonathan Andrus, vice president, clinical data management & regulatory operations at BioClinica's eClinical service division, has been elected as the Drug Information Association (DIA) North American Special Interest Area Communities (SIAC) eClinical Chair.
View press release
BioClinica's Express Platform Receives CDISC Certification Bio-Imaging Technologies, Inc., (NASDAQ: BITI) d/b/a BioClinica, a leading global provider of clinical trial services, has announced that its Express EDC platform has been certified by the Clinical Data Interchange Standard Consortium (CDISC) as complying with the Operational Data Model (ODM) standard.
View press release